Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
|
|
United Press International - Tuesday, May 25, 2004
Researchers at Stanford University School of Medicine said the process used the patient's stem cells -- ones in the bloodstream that form the different immune system cell that HIV infects, such as T cells and macrophages -- and inserts a gene that produces an HIV-obliterating enzyme.
"This is a broad-spectrum treatment that could integrate well with other therapies as the disease progresses, as it will in all patients eventually," said Thomas Merigan, who is collaborating with other researchers at UCLA and St. Vincent's Hospital in Sydney, Australia. "The goal is to genetically engineer the cells and make them resistant to infection."
A total of 70 patients will be enrolled at three sites for this stage of the testing and given gene therapy or a dummy gene.
040525
UP040506
Copyright © 2004 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .